ALS drug from Denali, Sanofi falls short in mid-stage study
BioPharma
Source: biopharmadive.com
📰 Michael Yee News
Page 7 - Michael Yee News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Yee. Real-time updates on events, politics, business and more.
Biogen Stock Drops as Earnings and Guidance Disappoint
Biogen’s new CEO, Christopher Viehbacher, said the company is well positioned to return to sustainable growth.
Michael Yee Josh Nathan Kazis Christopher Viehbacher Vanessa Leroy Bloomberg Drug Administration Wall Street
Source: marketwatch.com
Biogen (BIIB) Q4 2023 Earnings Call Transcript
BIIB earnings call for the period ending December 31, 2023.
Source: yahoo.com
Biogen (BIIB) Q4 2023 Earnings Call Transcript
BIIB earnings call for the period ending December 31, 2023.
Source: fool.com
Moderna's RSV Vaccine May Lose Efficacy Faster Than GSK and Pfizer's
Moderna shares were falling after the biotech revealed data that might hurt its vaccine’s competitive position.
Source: marketwatch.com
Gilead quarterly revenue drops 4%, oral COVID drug fails trial
By Deena Beasley (Reuters) -Gilead Sciences on Tuesday said fourth-quarter revenue dipped 4% on lower sales of HIV drugs and its infused COVID-19 treatment ...
Source: saltwire.com
Gilead Sciences (GILD) Q4 2023 Earnings Call Transcript
GILD earnings call for the period ending December 31, 2023.
United States Mike Yee Jefferies Olivia Brayer Cantor Fitzgerald Geoff Meacham Jacquie Ross Colin Bristow
Source: yahoo.com
Amgen Inc. (NASDAQ:AMGN) Q4 2023 Earnings Call Transcript
Amgen Inc. beats earnings expectations. Reported EPS is $4.71, expectations were $4.66.
Source: insidermonkey.com